Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bramson vehicle buys more shares in F&C

Tue, 15th Mar 2011 17:05

F&C Asset Management chairman Edward Bramson's investment vehicle SIGA LP has acquired more shares in the asset management company. Bramson was appointed chairman of F&C last month after a shareholder coup removed the previous incumbent, along with another non-executive, and appointed three new directors, including Bramson. SIGA has acquired 125,852 shares at 77.59p each. That cost £97,649 and followed the purchase of 265,000 shares at 77.79p each on Friday. SIGA has invested just over £300,000 in F&C shares in the past few days. SIGA owns around 18.1% of F&C and this is also deemed to be Bramson's holding. SIGA uses funds supplied by AIM-quoted Sherborne Investors to invest in F&C. The F&C share price has been falling back in recent weeks and it is around 10% lower over the past month. There are concerns that some asset management clients will desert F&C."Our focus now is to build on the things that work well at F&C and to improve the group's financial performance, which will create value for shareholders," according to Bramson when the company released its 2010 figures last Wednesday. A profit before tax a year ago was turned to a loss of £19.2m this time. The previous year's number benefited from a £27.9m debt exchange programme. Assets under management rose to £105.8bn from £97.8bn at the end of 2009, helped by £4.2bn from the acquisition of Thames River Capital in September. Net revenues increased to £243.2m from £225.1m, including performance related management fees of £12.9m, down from £18.7m the year before. Top Director Buys Travis Perkins (TPK) Director name: Mr Geoff CooperAmount purchased: 16,395 @ 968.19p Value: £158,735F&C Asset Management (FCAM) Director name: Mr Edward BramsonAmount purchased: 125,852 @ 77.59p Value: £97,649Travis Perkins (TPK) Director name: Mr Paul N Hampden SmithAmount purchased: 9,856 @ 968.19p Value: £95,425Travis Perkins (TPK) Director name: Mr John P CarterAmount purchased: 9,856 @ 968.19p Value: £95,425Travis Perkins (TPK) Director name: Mr Andrew PikeAmount purchased: 2,666 @ 968.19p Value: £25,812CLS Holdings (CLI) Director name: Mr H O Thomas LundqvistAmount purchased: 3,500 @ 650.00p Value: £22,750Anite (AIE) Director name: Mr David Hurst-BrownAmount purchased: 30,000 @ 65.55p Value: £19,665Anite (AIE) Director name: Mr Nigel CliffordAmount purchased: 30,000 @ 65.55p Value: £19,665e-Therapeutics (ETX) Director name: Mr Steve SelfAmount purchased: 50,000 @ 36.50p Value: £18,250Anite (AIE) Director name: Mr Richard AmosAmount purchased: 25,000 @ 65.55p Value: £16,388Top Director SellsSchroders (SDR) Director name: Mr Alan BrownAmount sold: 32,154 @ 1,734.00p Value: £557,550Prudential (PRU) Director name: Mr Mike WellsAmount sold: 31,478 @ 718.75p Value: £226,248Mondi (MNDI) Director name: Mr Peter OswaldAmount sold: 62,090 @ 553.26p Value: £343,519Novae Group (NVA) Director name: Mr Jeremy AdamsAmount sold: 65,612 @ 387.90p Value: £254,509Novae Group (NVA) Director name: Mr Oliver CorbettAmount sold: 65,612 @ 387.90p Value: £254,509Novae Group (NVA) Director name: Mr Matthew K FoshAmount sold: 65,612 @ 387.90p Value: £254,509Mondi (MNDI) Director name: Mr David A HathornAmount sold: 32,998 @ 553.26p Value: £182,565Mondi (MNDI) Director name: Mr Andrew KingAmount sold: 10,550 @ 553.26p Value: £58,369Mondi (MNDI) Director name: Ms Carol HuntAmount sold: 10,153 @ 553.26p Value: £56,172
More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.